Drugs and Devices

FDA approves new type of drug for insomnia

On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor antagonist. Read more

Shares



Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares